Yong-hong Xiao - Infectious Diseases

Author Information

Yonghong Xiao is a prominent researcher affiliated with the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases at Zhejiang University, located in Hangzhou, Zhejiang, China. His work is primarily associated with the First Affiliated Hospital of Medicine School, where he contributes to the Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases. His research is deeply embedded in the field of infectious diseases, focusing on understanding and combating various bacterial pathogens and pandemics.

Research Contributions

Yonghong Xiao has made significant contributions to the field of infectious diseases, particularly in understanding the genetic epidemiology and resistance mechanisms of various bacterial pathogens. In 2021 alone, he co-authored several papers that address critical issues such as carbapenem-resistant Enterobacteriaceae, methicillin-resistant Staphylococcus aureus, and colistin resistance in Escherichia coli. His research also extends to analyzing global pandemics like COVID-19, with work on predicting hosts based on early SARS-CoV-2 samples. Yonghong Xiao's research is pivotal in addressing antimicrobial resistance and improving treatment outcomes for bacterial infections.

Aliases

Yonghong Xiao is also known by the aliases "Yong-hong Xiao" and "Yonghong Xiao." These variations may appear in different publications or databases.

Publication and Citation Metrics

Metric	Count
Total Papers	207
Total Citations	31,228
h-index	50

Publications:

Predicting Hosts Based on Early SARS-CoV-2 Samples and Analyzing Later World-wide Pandemic in 2020

DOI: 10.21203/RS.3.RS-404213/V1

Year: 2021

Predicting hosts based on early SARS-CoV-2 samples and analyzing the 2020 pandemic

DOI: 10.1038/s41598-021-96903-6

Year: 2021

Rapid increase in occurrence of carbapenem-resistant Enterobacteriaceae in healthy rural residents in Shandong province, China, from 2015 to 2017.

DOI: 10.1016/j.jgar.2021.11.007

Year: 2021

Genomic Epidemiology and Characterization of Methicillin-Resistant Staphylococcus aureus from Bloodstream Infections in China

DOI: 10.1128/mSystems.00837-21

Year: 2021

Carbapenem-resistant Acinetobacter Baumannii Ventilator-Associated Pneumonia in Critically Ill Patients: Potential Inference with Respiratory Tract Microbiota Dysbiosis

DOI: 10.21203/RS.3.RS-736916/V1

Year: 2021

[Knockdown of calreticulin increases intracellular Ca2+ concentration and promotes apoptosis of HSC-LX2 human hepatic stellate cells].

DOI:

Year: 2021

Acquisition of the mcr-1 Gene Lowers the Target Mutation to Impede the Evolution of a High-Level Colistin-Resistant Mutant in Escherichia coli

DOI: 10.2147/IDR.S324303

Year: 2021

Antibacterial Activity and Optimal Treatment of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Bloodstream Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae

DOI: 10.3389/fphar.2021.771910

Year: 2021

Global dissemination of tet(X3) and tet(X6) among livestock-associated Acinetobacter is sporadic and mediated by highly diverse plasmidomes

DOI: 10.1101/2021.08.02.454847

Year: 2021

Comparative Genomic Analysis Provides Insights into the Evolution and Genetic Diversity of Community-Genotype Sequence Type 72 Staphylococcus aureus Isolates

DOI: 10.1128/mSystems.00986-21

Year: 2021

Are there any public health concerns?

What are the Challenges in Studying Parasite DNA?

What Are the Direct Effects of Climate Change on Disease Vectors?

What Technologies are Used in Genomic and Proteomic Studies?

How Are Bacterial Infections Diagnosed?

Why Are Vaccinations Important in Infectious Diseases?

What is Herpes Simplex Virus (HSV)?

How is it diagnosed?

Can Asymptomatic Individuals Develop Symptoms Later?

What is an Infectious Disease Surveillance System?

Partnered Content Networks

Relevant Topics